Contributing Author John Vandermosten, Senior Biotechnology Analyst Cell therapy is the transfer of therapeutic cells to a patient. It replaces damaged cells or enhances normal cells with modified new ones. The cells used in the process may be autologous or allogeneic; however, they must be recognized by the immune system in a way that will promote the desired response. Some cell… [Read More]
Big Picture Cancer is a leading cause of death worldwide. In the U.S., only heart disease ranks above it. The American Cancer Society estimates that in the U.S. in 2021, there will be nearly 2 million new cancer cases and more than 600,000 cancer deaths from all types of cancer combined. However, our individual immune systems have a variety… [Read More]
Big Picture Genomic medicine is bringing hope where none previously existed. This approach to cure and treat human diseases uses human biology rather than chemical compounds made in the lab to unlock techniques and therapies with the power to cure formerly incurable diseases. The use of gene therapy, CAR T cell therapy, stem cell, and other therapies is revolutionizing… [Read More]
Contributing Author: Gina Hagler Maryland is home to one of the largest life science clusters in the United States with more than 500 biotech companies. In addition to several state-of-the-art labs, Maryland is home to the NIH in Bethesda. Research opportunities, as well as BS and MS degree programs, are offered at Johns Hopkins in Baltimore and the University of Maryland… [Read More]
Today Human immunity is a beautifully complex system. Students of science around the world groan at the mention of immunology because of its never-ending overlapping cell types and pathways. Those groans are being replaced with genuine interest as immuno-oncology becomes a reality. Excitement exploded in 2017 when two cancer treatments that modify immune cells (CAR-T) were approved by the U.S…. [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!